Fabrice Delaye

Ten years after Dotcom crash, the Nasdaq is still 55% below its March 2000 peak. But the Internet is now spawning a new generation of dotcoms.

Created to be for robots what Windows has been for the PC, Jean-Christophe Baillie’s company Gostai is leapfrogging the chasm between lab and markets.

There is still uncertainty among investors about the commercial promise of the emerging field of personalised medicine.

Philippe Swennen of the Association Internationale de la Mutualité tells Fabrice Delaye how insurers feel about the advent of personalised healthcare.

The drawbacks of Open Innovation are more than made up for by its advantages, say leading entrepreneurs Marc de Garidel and Andrew Lynn.

France is to invest €35 billion in new funding for universities and innovation, and looks forward to a new “Golden Era”.

France’s newly autonomous universities are setting out to create foundations on the model of Harvard and Yale – and getting caught up in France’s bureaucratic jungle.

In a series of six articles, Science|Business looks at how the G-20’s $200 billion of stimulus money will be spent. This week, France.

The Swiss entrepreneurship education programme Venturelab is already creating 100 start-ups a year. Now it aims to double its output.

Four of Europe’s leading micro and nanotechnology research bodies are reaching across national boundaries to create a single arm for grants and spin-outs.